Lead Product(s) : Clostridium Butyricum
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Linyi People's Hospital | Taian City Central Hospital | EA Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
November 25, 2015
Lead Product(s) : Clostridium Butyricum
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Linyi People's Hospital | Taian City Central Hospital | EA Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable